Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-25 @ 2:32 AM
NCT ID:
NCT05986734
Eligibility Criteria:
Inclusion Criteria:
* Patients of both sexes over the age of 0 years with a verified diagnosis of primary immunodeficiency, who require regular immunoglobulin replacement therapy
* Patients' and/or their legal representatives' (for patients under 14 years of age) consent to participate in the study
Exclusion Criteria:
* Hypersensitivity to the study drug or any component of the study drug
* Active oncological disease
* Condition after haematopoietic stem cell transplantation
* Use of other immunoglobulin products during the study drug therapy.
* Discontinuation or irregular use of the study drug
Sex:
ALL
Minimum Age:
1 Day
Maximum Age:
18 Years
Study:
NCT05986734
Study Brief:
Protocol Section:
NCT05986734